Works by Marti, Thomas Michael


Results: 9
    1
    2
    3
    4
    5

    An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4457, doi. 10.1007/s00262-023-03542-z
    By:
    • Deng, Haibin;
    • Ge, Huixiang;
    • Dubey, Christelle;
    • Losmanova, Tereza;
    • Medová, Michaela;
    • Konstantinidou, Georgia;
    • Mutlu, Seyran Mathilde;
    • Birrer, Fabienne Esther;
    • Brodie, Tess Melinda;
    • Stroka, Deborah;
    • Wang, Wenxiang;
    • Peng, Ren-Wang;
    • Dorn, Patrick;
    • Marti, Thomas Michael
    Publication type:
    Article
    6

    Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5′-deoxy-5-fluorocytidine (5′-DFCR).

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01938-2
    By:
    • Gao, Yanyun;
    • Zens, Philipp;
    • Su, Min;
    • Gemperli, Camila Anna;
    • Yang, Haitang;
    • Deng, Haibin;
    • Yang, Zhang;
    • Xu, Duo;
    • Hall, Sean R. R.;
    • Berezowska, Sabina;
    • Dorn, Patrick;
    • Peng, Ren-Wang;
    • Schmid, Ralph Alexander;
    • Wang, Wenxiang;
    • Marti, Thomas Michael
    Publication type:
    Article
    7
    8
    9